Physician profile
Steven Mark Walters
NPI 1306887070
$416.09
in general payments reported to CMS, 2019-2025
11 companies · $35.40 in 2025
The $35.40 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.15 · 2020: $29.94 · 2021: $23.08 · 2023: $37.96 · 2024: $231 · 2025: $35.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $303.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $150.99 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $44.83 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $36.08 | 2024 | Xarelto |
| Stryker Corporation | $35.40 | 2025 | Ortholoc 3di |
| Melinta Therapeutics, LLC | $26.71 | 2019 | |
| Pfizer INC. | $23.08 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.25 | 2024 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $21.24 | 2024 | |
| Gilead Sciences, INC. | $20.77 | 2023 | Veklury |
| Boston Scientific Corporation | $17.55 | 2019 | |
| Abbott Laboratories | $17.19 | 2023 | Freestyle Libre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.